Skip to content

SB 866 · Pennsylvania · 2025-2026 · Billy

Skip to content

Home
/
Bills
/
Pennsylvania
/
2025-2026
/
SB 866

Pennsylvania · 2025-2026 session · senate

SB 866An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for schedules of controlled substances and for secure storage of xylazine; and adding provisions relating to medetomidine.

Status: Passed chamber
Latest action: 2026-06-10 — Referred to Judiciary
Primary sponsor: Michele Brooks (Republican)

Track this bill

Sponsors

Michele Brooks (Republican) · primaryprimary
Doug Mastriano (Republican) · cosponsor
Christine Tartaglione · cosponsor
Lisa Boscola (Democratic) · cosponsor

Public legislative record via Billy. Sign in to track, annotate, and export work product.

About public bill pages Compare Billy Pennsylvania bill RSS

Christine Tartaglione (Democratic) · cosponsor

Versions

Printer's No. PN1082—

Legislative history

Jun 10, 2026
Referred to Judiciary
Jun 9, 2026
Third consideration and final passage
Jun 8, 2026
Re-reported as committed
Jun 3, 2026
Second consideration
Jun 3, 2026
Re-referred to Appropriations
Jun 2, 2026
First consideration
Jun 2, 2026
Reported as committed
Jul 24, 2025
Referred to Agriculture & Rural Affairs

Official sources

Version 0PDF HTML DOCX

Senate Fiscal NotePDF

About this page

Is this the official Pennsylvania bill page?: No — this is Billy’s public legislative record for SB 866. Official source links are listed above when publishers provide them.
Can I track updates?: Yes. Sign in to track SB 866, get alerts, annotate diffs, and export Word work product.